Effects of vitamin E supplementation on plasma membrane permeabilization and fluidization induced by chlorpromazine in the rat brain

Journal of Psychopharmacology

Volumn 22, Issue 2, 2008, Pages 119-127

  Maruoka, Nobuyuki ^a   Murata, Tetsuhito ^a   Omata, Naoto ^a   Takashima, Yasuhiro ^a   Fujibayashi, Yasuhisa ^a   Wada, Yuji ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Chlorpromazine; Extrapyramidal side effects; Membrane fluidity; Membrane permeability; Striatal slices; Vitamin E

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; ALPHA TOCOPHEROL; ANTIOXIDANT; CHLORPROMAZINE; FLUORODEOXYGLUCOSE F 18; N TERT BUTYL ALPHA PHENYLNITRONE; NEUROTRANSMITTER RECEPTOR; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANISOTROPY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL MEMBRANE FLUIDITY; CELL MEMBRANE PERMEABILITY; CELL PERMEABILIZATION; CONTROLLED STUDY; DRUG EFFECT; FLUORESCENCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATE CORTEX; VITAMIN SUPPLEMENTATION;

ALPHA-TOCOPHEROL; ANIMALS; ANISOTROPY; ANTIOXIDANTS; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; BRAIN; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CHLORPROMAZINE; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORODEOXYGLUCOSE F18; GLUCOSE-6-PHOSPHATE; MALE; MEMBRANE FLUIDITY; RATS; RATS, WISTAR;

EID: 40049086233     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107078487     Document Type: Article

References (86)

1. Adler L.A., Edson R., Lavori P., Peselow E., Duncan E., Rosenthal M., Rotrosen J. (1998) Long-term treatment effects of vitamin E for tardive dyskinesia. Biol Psychiatry 43: 868 - 872
2. Adler L.A., Peselow E., Rotrosen J., Duncan E., Lee M., Rosenthal M., Angrist B. (1993) Vitamin E treatment of tardive dyskinesia. Am J Psychiatry 150: 1405 - 1407
3. Andreoli S.P., Baehner R.L., Bergstein J.M. (1985) In vitro detection of endothelial cell damage using 2-deoxy-D-3H-glucose: comparison with chromium 51, 3H-leucine, 3H-adenine, and lactate dehydrogenase. J Lab Clin Med 106: 253 - 261
4. Ashwell J.D., Schwartz R.H., Mitchell J.B., Russo A. (1986) Effect of gamma radiation on resting B lymphocytes. I. Oxygen-dependent damage to the plasma membrane results in increased permeability and cell enlargement. J Immunol 136: 3649 - 3656
5. Avdulov N.A., Chochina S.V., Igbavboa U., O'Hare E.O., Schroeder F., Cleary J.P., Wood W.G. (1997) Amyloid ®-peptides increase annular and bulk fluidity and induce lipid peroxidation in brain synaptic plasma membranes. J Neurochem 68: 2086 - 2091
6. Balijepalli S., Boyd M.R., Ravindranath V. (1999) Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation. Neuropharmacology 38: 567 - 577
7. Bartels M., Themelis J. (1983) Computerized tomography in tardive dyskinesia. Evidence of structural abnormalities in the basal ganglia system. Arch Psychiatr Nervenkr 233: 371 - 379
8. Behl C., Rupprecht R., Skutella T., Holsboer F. (1995) Haloperidol-induced cell death-mechanism and protection with vitamin E in vitro Neuroreport 7: 360-364
9. Brown K.W., Wardlaw J.M., White T., Walker N. (1996) Caudate nucleus area in drug-induced parkinsonism. Acta Psychiatr Scand 94: 348 - 351
10. Burkhardt C., Kelly J.P., Lim Y.H., Filley C.M., Parker W.D. Jr (1993) Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol 33: 512 - 517
11. Carney J.M., Floyd R.A. (1991) Protection against oxidative damage to CNS by α-phenyl-tert-butyl nitrone (PBN) and other spin-trapping agents: a novel series of nonlipid free radical scavengers. J Mol Neurosci 3: 47 - 57
12. Carney J.M., Starke-Reed P.E., Oliver C.N., Landum R.W., Cheng M.S., Wu J.F., Floyd R.A. (1991) Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-α- phenylnitrone. Proc Natl Acad Sci USA 88: 3633 - 3636
13. Chen S., Gjerde A.U., Holmsen H., Nerdal W. (2005) Importance of polyunsaturated acyl chains in chlorpromazine interaction with phosphatidylserines: a 13C and 31P solid-state NMR study. Biophys Chem 117: 101 - 109
14. Conley R.R., Kelly D.L. (2005) Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects. Isr J Psychiatry Relat Sci 42: 51 - 60
15. Coombes J.S., Powers S.K., Demirel H.A., Jessup J., Vincent H.K., Hamilton K.L., Naito H., Shanely R.A., Sen C.K., Packer L., Ji L.L. (2000) Effect of combined supplementation with vitamin E and alpha-lipoic acid on myocardial performance during in vivo ischaemia-reperfusion. Acta Physiol Scand 169: 261 - 269
16. Diplock A.T., Lucy J.A. (1973) The biochemical modes of action of vitamin E and selenium: A hypothesis. FEBS Lett 29: 205 - 210
17. Dwyer D.S., Lu X.H., Bradley R.J. (2003) Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism. Brain Res 971: 31 - 39
18. Egan M.F., Apud J., Wyatt R.J. (1997) Treatment of tardive dyskinesia. Schizophr Bull 123: 583 - 609
19. Egan M.F., Hyde T.M., Albers G.W., Elkashef A., Alexander R.C., Reeve A., Blum A., Saenz R.E., Wyatt R.J. (1992) Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry 149: 773 - 777
20. Elkashef A.M., Ruskin P.E., Bacher N., Barrett D. (1990) Vitamin E in the treatment of tardive dyskinesia. Am J Psychiatry 147: 505 - 506
21. Fukuzawa K., Chida H., Suzuki A. (1980) Fluorescence depolarization studies of phase transition and fluidity in lecithin liposomes containing αtocopherol. J Nutr Sci Vitaminol 26: 427 - 434
22. Fukuzawa K., Hayashi K., Suzuki A. (1977) Effects of α-tocopherol analogs on lysosome membranes and fatty acid monolayers. Chem Phys Lipids 18: 39 - 48
23. Fukuzawa K., Ikeno H., Tokumura A., Tsukatani H. (1979) Effect of α-tocopherol incorporation of glucose permeability and phase transition of lecithin liposomes. Chem Phys Lipids 23: 13 - 21
24. Galili-Mosberg R., Gil-Ad I., Weizman A., Weizman A., Melamed E., Offen D. (2000) Haloperidol-induced neurotoxicity - possible implications for tardive dyskinesia. J Neural Transm 107: 479 - 490
25. Gerlach J., Casey D.E. (1988) Tardive dyskinesia. Acta Psychiatr Scand 77: 369 - 378
26. Goldstein D.B. (1984) The effects of drugs on membrane fluidity. Annu Rev Pharmacol Toxicol 24: 43 - 64
27. Gray E.G., Whittaker V.P. (1962) The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat 96: 79 - 88
28. Grohmann R., Koch R., Schmidt L.G. (1990) Extrapyramidal symptoms in neuroleptic recipients. Agents Actions Suppl 29: 71 - 82
29. Hägerstrand H., Danieluk M., Bobrowska-Hägerstrand M., Igliç A., Wróbel A., Isomaa B., Nikinmaa M. (2000) Influence of band 3 protein absence and skeletal structures on amphiphile- and Ca2+-induced shape alterations in erythrocytes: a study with lamprey (Lampetra fluviatilis). trout (Onchorhynchus mykiss) and human erythrocytes. Biochim Biophys Acta 1466: 125 - 138
30. Hamacher K., Coenen H.H., Stocklin G. (1986) Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27: 235 - 238
31. Haramaki N., Assadnazari H., Zimmer G., Schepkin V., Packer L. (1995) The influence of vitamin E and dihydrolipoic acid on cardiac energy and glutathione status under hypoxia-reoxygenation. Biochem Mol Biol Int 37: 591 - 597
32. Haramaki N., Packer L., Assadnazari H., Zimmer G. (1993) Cardiac recovery during post-ischemic reperfusion is improved by combination of vitamin E with dihydrolipoic acid. Biochem Biophys Res Commun 196: 1101 - 1107
33. Holmsen H., Rygh T. (1990) Chlorpromazine makes the platelet plasma membrane permeable for low-molecular weight substances and reduces ATP production. Biochem Pharmacol 40: 373 - 376
34. Huang J., Tanii H., Ohyashiki T., Hashimoto K. (1993) Structure-toxicity relationship of monoketones: in vitro effects on beta-adrenergic receptor binding and Na+/K+-ATPase activity in mouse synaptosomes. Neurotoxicol Teratol 15: 345 - 352
35. Hueck I.S., Hollweg H.G., Schmid-Schonbein G.W., Artmann G.M. (2000) Chlorpromazine modulates the morphological macro- and microstructure of endothelial cells. Am J Physiol Cell Physiol 278: C873
36. Janero D.R. (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9: 515 - 540
37. Jeste D.V., Caligiuri M.P. (1993) Tardive dyskinesia. Schizophr Bull 19: 303 - 315
38. Katsu T., Kobayashi H., Hirota T., Fujita Y., Sato K., Nagai U. (1987) Structureactivity relationship of gramicidin S analogues on membrane permeability. Biochim Biophys Acta 899: 159 - 170
39. Katsu T., Kuroko M., Morikawa T., Sanchika K., Fujita Y., Yamamura H., Uda M. (1989) Mechanism of membrane damage induced by the amphipathic peptides gramicidin S and melittin. Biochim Biophys Acta 983: 135 - 141
40. Katsu T., Kuroko M., Morikawa T., Sanchika K., Yamanaka H., Shinoda S., Fujita Y. (1990) Interaction of wasp venom mastoparan with biomembranes. Biochim Biophys Acta 1027: 185 - 190
41. Katsu T., Nakao S., Iwanaga S. (1993) Mode of action of an antimicrobial peptide, tachyplesin I, on biomembranes. Biol Pharm Bull 16: 178 - 181
42. Klawans H.L., Goetz C.G., Perlik S. (1980) Tardive dyskinesia: review and update. Am J Psychiatry 137: 900 - 908
43. Kristensen S.R., Horder M. (1988) Release of enzymes from quiescent fibroblasts during ATP depletion. Enzyme 39: 205 - 212
44. Lieberman J.A. (2004) Dopamine partial agonists: a new class of antipsychotic. CNS Drugs 18: 251 - 267
45. Lohr J.B., Cadet J.L., Lohr M.A., Larson L., Wasli E., Wade L., Hylton R., Vidoni C., Jeste D.V., Wyatt R.J. (1988) Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. Schizophr Bull 14: 291 - 296
46. Lohr J.B., Caligiuri M.P. (1996) A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry 57: 167 - 173
47. Machlin L.J., Gabriel E. (1982) Kinetics of tissue α-tocopherol uptake and depletion following administration of high levels of vitamin E. Ann NY Acad Sci 393: 48 - 60
48. Malik J.K., Schwarz L.R., Wiebel F.J. (1983) Assessment of membrane damage in continuous cultures of mammalian cells. Chem Biol Interact 45: 29 - 42
49. Margolese H.C., Chouinard G., Kolivakis T.T., Beauclair L., Miller R. (2005) Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction. Can J Psychiatry 50: 541 - 547
50. Marsden C.D., Jenner P. (1980) The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med 10: 55 - 72
51. Maurer I., Möller H.J. (1997) Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Mol Cell Biochem 174: 255 - 259
52. Miller R., Chouinard G. (1993) Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced super-sensitivity psychosis and refractory schizophrenia. Biol Psychiatry 34: 713 - 738
53. Mion C.C., Andreasen N.C., Arndt S., Swayze II V W, Cohen G.A. (1991) MRI abnormalities in tardive dyskinesia. Psychiatry Res 40: 157 - 166
54. Murata T., Omata N., Fujibayashi Y., Waki A., Sadato N., Yoshida S., Yano R., Yoshimoto M., Yonekura Y. (1999) Dynamic changes in glucose metabolism of living rat brain slices induced by hypoxia and neurotoxic chemical-loading revealed by positron autoradiography. J Neural Transm 106: 1075 - 1087
55. Niki E. (1987) Antioxidants in relation to lipid peroxidation. Chem Phys Lipids 44: 227 - 253
56. Noji S., Takahashi T., Kon H. (1982) A spin-label study of the correlation between stomatocyte formation and membrane fluidization of erythrocytes. Biochem Pharmacol 31: 3173 - 3180
57. Ohyashiki T., Sakata N., Matsui K. (1992) A decrease of lipid fluidity of the porcine intestinal brush-border membranes by treatment with malondialdehyde. J Biochem 111: 419 - 423
58. Omata N., Murata T., Fujibayashi Y., Waki A., Sadato N., Yoshimoto M., Wada Y., Yonekura Y. (2000) Hypoxic but not ischemic neurotoxicity of free radicals revealed by dynamic changes in glucose metabolism of fresh rat brain slices on positron autoradiography. J Cereb Blood Flow Metab 20: 350 - 358
59. Pai B.N., Janakiramaiah N., Gangadhar B.N., Ravindranath V. (1994) Depletion of glutathione and enhanced lipid peroxidation in the CSF of acute psychotics following haloperidol administration. Biol Psychiatry 36: 489 - 491
60. Post A., Holsboer F., Behl C. (1998) Induction of NF-κB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-κB and neuroprotection by antioxidants. J Neurosci 18: 8236 - 8246
61. Rajput A.H., Rozdilsky B., Hornykiewicz O., Shannak K., Lee T., Seeman P. (1982) Reversible drug-induced parkinsonism. Clinicopathological study of two cases. Arch Neurol 39: 644 - 646
62. Rissanen E., Krumschnabel G., Nikinmaa M. (2003) Dehydroabietic acid, a major component of wood industry effluents, interferes with cellular energetics in rainbow trout hepatocytes. Aquat Toxicol 62: 45 - 53
63. Sack C.A., Socci D.J., Crandall B.M., Arendash G.W. (1996) Antioxidant treatment with phenyl-α-tert-butyl nitrone (PBN) improves the cognitive performance and survival of aging rats. Neurosci Lett 205: 181 - 184
64. Sagara Y. (1998) Induction of reactive oxygen species in neurons by haloperidol. J Neurochem 71: 1002 - 1012
65. Scuntaro I., Kientsch U., Wiesmann U.N., Honegger U.E. (1996) Inhibition by vitamin E of drug accumulation and of phospholipidosis induced by desipramine and other cationic amphiphilic drugs in human cultured cells. Br J Pharmacol 119: 829 - 834
66. Seeman P., Staiman A., Lee T., Chau-Wong M. (1974) The membrane actions of tranquilizers in relation to neuroleptic-induced parkinsonism and tardive dyskinesia. Adv Biochem Psychopharmacol 9: 137 - 148
67. Sergent O., Pereira M., Belhomme C., Chevanne M., Huc L., Lagadic-Gossmann D. (2005) Role for membrane fluidity in ethanol-induced oxidative stress of primary rat hepatocytes. J Pharmacol Exp Ther 313: 104 - 111
68. Sheetz M.P., Singer S.J. (1974) Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci USA 71: 4457 - 4461
69. Shinitzky M., Barenholz Y. (1978) Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim Biophys Acta 515: 367 - 394
70. Shinitzky M., Inbar M. (1976) Microviscosity parameters and protein mobility in biological membranes. Biochim Biophys Acta 433: 133 - 149
71. Shivakumar B.R., Ravindranath V. (1992) Oxidative stress induced by administration of the neuroleptic drug haloperidol is attenuated by higher doses of haloperidol. Brain Res 595: 256 - 262
72. Shivakumar B.R., Ravindranath V. (1993) Oxidative stress and thiol modification induced by chronic administration of haloperidol. J Pharmacol Exp Ther 265: 1137 - 1141
73. Silvestri S., Seeman M.V., Negrete J.C., Houle S., Shammi C.M., Remington G.J., Kapur S., Zipursky R.B., Wilson A.A., Christensen B.K., Seeman P. (2000) Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology 152: 174 - 180
74. Tanii H., Huang J., Ohyashiki T., Hashimoto K. (1994) Physical-chemicalactivity relationship of organic solvents: effects on Na+/K+-ATPase activity and membrane fluidity in mouse synaptosomes. Neurotoxicol Teratol 16: 575 - 582
75. Tanii H., Zhang X.P., Ohyashiki T. (1995) In vitro influences of alcohols on mouse synaptosomes, and structure-activity relationships. Arch Toxicol 69: 617 - 623
76. Tharmapathy P., Fukami M.H., Holmsen H. (2000) The stimulatory effects of cationic amphiphilic drugs on human platelets treated with thrombin. Biochem Pharmacol 60: 1267 - 1277
77. Tsai A.C., Kelley J.J., Peng B., Cook N. (1978) Study on the effect of megavitamin E supplementation in man. Am J Clin Nutr 31: 831 - 837
78. Urano S., Asai Y., Makabe S., Matsuo M., Izumiyama N., Ohtsubo K., Endo T. (1997) Oxidative injury of synapse and alteration of antioxidative defense systems in rats, and its prevention by vitamin E. Eur J Biochem 245: 64 - 70
79. Urano S., Iida M., Otani I. Matsuo M (1987) Membrane stabilization of vitamin E; interactions of α-tocopherol with phospholipids in bilayer liposomes. Biochem Biophys Res Commun 146: 1413 - 1418
80. Urano S., Yano K., Matsuo M. (1988) Membrane-stabilizing effect of vitamin E: effect of α-tocopherol and its model compounds on fluidity of lecithin liposomes. Biochem Biophys Res Commun 150: 469 - 475
81. Volles M.J., Lansbury P.T. Jr (2002) Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41: 4595 - 4602
82. Volles M.J., Lee S.J., Rochet J.C., Shtilerman M.D., Ding T.T., Kessler J.C., Lansbury P.T. Jr (2001) Vesicle permeabilization by protofibrillar αsynuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40: 7812 - 7819
83. Waddington J.L. (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101: 431 - 447
84. Walum E., Peterson A. (1982) Tritiated 2-deoxy-D-glucose as a probe for cell membrane permeability studies. Anal Biochem 120: 8 - 11
85. Yabuki M., Tani N., Yoshioka T., Nishibe H., Kanamaru H., Kaneko H. (2000) Local thrombus formation in the site of intravenous injection of chlorpromazine: possible colloid-osmotic lysis of the local endothelial cells. Biol Pharm Bull 23: 957 - 961
86. Yokoyama H., Kasai N., Ueda Y., Niwa R., Konaka R., Mori N., Tsuchihashi N., Matsue T., Ohya-Nishiguchi H., Kamada H. (1998) In vivo analysis of hydrogen peroxide and lipid radicals in the striatum of rats under longterm administration of a neuroleptic. Free Radic Biol Med 24: 1056 - 1060